Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1126 AL 1140

[Posttraumatic stress disorder clinical guidelines and treatment standards: focus on the symptoms of the psychophysiological arousal]

Vasileva AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(5):58-68. doi: 10.17116/jnevro202412405158.

Comparison of efficacy and safety of etomidate with other anesthesia induction drugs for patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized controlled trials

Xia Z, Kamra K, Dong J, Harp KA, Xiong Y, Lisco SJ, Zucker IH, Wang HJ.

Heliyon. 2024 Sep 21;10(22):e38274. doi: 10.1016/j.heliyon.2024.e38274. eCollection 2024 Nov 30.

Enhancing Aviation Safety through AI-Driven Mental Health Management for Pilots and Air Traffic Controllers

Ćosić K, Popović S, Wiederhold BK.

Cyberpsychol Behav Soc Netw. 2024 Aug;27(8):588-598. doi: 10.1089/cyber.2023.0737. Epub 2024 Jun 25.

Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy

Cannilla H, Messe M, Girardin F, Borruat FX, Bally JF.

Tremor Other Hyperkinet Mov (N Y). 2024 May 8;14:23. doi: 10.5334/tohm.832. eCollection 2024.

Effect of Pretreatment with a Small Dose of Esketamine on Myoclonus Induced by Etomidate: A Randomized Controlled Trial

Gao L, Lu X, Tan A, Liufu J, Xu Y, Wei L.

Drug Des Devel Ther. 2024 Dec 7;18:5773-5779. doi: 10.2147/DDDT.S495130. eCollection 2024.

The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns

Baldo BA.

Arch Toxicol. 2024 Aug;98(8):2409-2427. doi: 10.1007/s00204-024-03765-8. Epub 2024 May 14.

Migraine With Aura Accompanied by Myoclonus: A Case Report

Hayashi K, Suzuki A, Nakaya Y, Takaku N, Miura T, Sato M, Kobayashi Y.

Cureus. 2024 Sep 9;16(9):e69046. doi: 10.7759/cureus.69046. eCollection 2024 Sep.

Characteristics of Creutzfeldt-Jakob disease at Siriraj Hospital, Thailand: Case series and literature review

Dumrikarnlert C, Kanokkawinwong N, Rattanabannakit C, Senanarong V.

Clin Park Relat Disord. 2024 Nov 17;11:100281. doi: 10.1016/j.prdoa.2024.100281. eCollection 2024.

A novel pathogenic variant in the KCTD7 gene in a patient with neuronal ceroid lipofuscinosis (CLN14): a case report and review of the literature

Zeineddin S, Matar G, Abosaif Y, Abunada M, Aldabbour B.

BMC Neurol. 2024 Sep 30;24(1):367. doi: 10.1186/s12883-024-03868-w.

Tranexamic Acid Neurotoxicity After Nebulization and BAL

Hardin J, Seltzer J, Moriguchi R, Yeung K, Galust H, Corbett B, Schneir A, Clark RF, Suhandynata RT.

Chest. 2024 Oct;166(4):e101-e103. doi: 10.1016/j.chest.2024.05.021.

COVID 19 and myoclonus, do hemodialysis patients have more risk?

Pol Heres SV, Aresté Fosalba N, Barragán-Prieto A, Aguilera Morales WA, Salgueira M.

Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):284-286. doi: 10.1016/j.nefroe.2024.03.015. Epub 2024 Apr 12.

Arousal, Gray's theory of anxiety, and the etiology of psychopathy

Fowles DC.

Biol Psychol. 2024 Apr;188:108772. doi: 10.1016/j.biopsycho.2024.108772. Epub 2024 Mar 9.

Autoimmune encephalitis in glial fibrillary acidic protein astrocytopathy

Zhao CW, Gheihman G, Nigam M, Manzano GS.

BMJ Case Rep. 2024 May 9;17(5):e260628. doi: 10.1136/bcr-2024-260628.

VAL-1221 for the treatment of patients with Lafora disease: study protocol for a single-arm, open-label clinical trial

Muccioli L, Vignatelli L, Tappatà M, Mazzone S, Zenesini C, Armstrong D; DEFEAT-LD study group; Michelucci R, Bisulli F.

BMJ Open. 2024 Oct 18;14(10):e085062. doi: 10.1136/bmjopen-2024-085062.

A rare case of tongue biting during sleep in childhood

Cascais I, Ashworth J, Ribeiro L, Freitas J, Rios M.

J Clin Sleep Med. 2024 Apr 1;20(4):653-656. doi: 10.5664/jcsm.10966.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias